Léa Jouve1, Jad Akesbi1, Jean-Philippe Nordmann1. Show Affiliations » 1. Ophthalmology Department, CHNO Quinze-Vingts, Paris, France.
Abstract
Entities: Chemical Species
Mesh: See more » AdultAngiogenesis Inhibitors/adverse effectsAngiogenesis Inhibitors/therapeutic useChoroidal Neovascularization/diagnosisChoroidal Neovascularization/drug therapyChoroidal Neovascularization/etiologyFemaleFluorescein AngiographyHumansIntravitreal InjectionsPregnancyRanibizumab/adverse effectsRanibizumab/therapeutic useSubretinal FluidTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity
Substances: See more » Angiogenesis InhibitorsVEGFA protein, humanVascular Endothelial Growth Factor ARanibizumab
Year: 2014 PMID: 25483229 DOI: 10.1111/aos.12611
Source DB: PubMed Journal: Acta Ophthalmol ISSN: 1755-375X Impact factor: 3.761